about
Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma.Toxicity of aflatoxin B1 towards the vitamin D receptor (VDR).Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies.Role of WT1-ZNF224 interaction in the expression of apoptosis-regulating genes.Monoclonal antibody-induced ErbB3 receptor internalization and degradation inhibits growth and migration of human melanoma cells.TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung.ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors.Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma
P50
Q38849622-C6DEC035-EF66-4D77-BED0-CD4FFFECF737Q38931275-CC6EFBF2-77FD-4249-9F27-6192137EEA32Q39119920-4E54BD1C-EC46-47BA-8900-BE140DDC2A0CQ39202260-9A934AF2-2091-42E4-B5E2-6F48730AEB0EQ39379086-D1C17DD4-0ADA-4BED-9AD6-52047D0B1BA3Q42090640-22C3444A-4A24-4B52-8A7C-8D29840DC148Q46177039-9BC9301A-2068-4873-A752-00F002B23AADQ91044879-6A6869B3-760A-4C2A-B9E6-EEC14133AA1A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Luigi Fattore
@ast
Luigi Fattore
@en
Luigi Fattore
@es
Luigi Fattore
@nl
Luigi Fattore
@sl
type
label
Luigi Fattore
@ast
Luigi Fattore
@en
Luigi Fattore
@es
Luigi Fattore
@nl
Luigi Fattore
@sl
prefLabel
Luigi Fattore
@ast
Luigi Fattore
@en
Luigi Fattore
@es
Luigi Fattore
@nl
Luigi Fattore
@sl
P106
P1153
55200759600
P21
P31
P496
0000-0002-9245-0126